ClinicalTrials.Veeva
Menu

Find clinical trials for Glioblastoma (GBM) in Rochester, MN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Glioblastoma
Recurrence
Brain Cancer
Glioma
Astrocytoma
Cancer
Gliosarcoma

Glioblastoma (GBM) trials near Rochester, MN, USA:

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma (GBM AGILE)

Glioblastoma (GBM) adaptive, global, innovative learning environment (GBM AGILE) is an international, seamless Phase II/II....

Enrolling
Glioblastoma
Drug: Temozolomide
Radiation: Radiation

Phase 2, Phase 3

Global Coalition for Adaptive Research

Rochester, Minnesota, United States and 61 other locations

with or without epacadostat in the treatment of recurrent glioblastoma (GBM). The investigators hypothesize that this combination p...

Active, not recruiting
Glioblastoma
Glioma
Drug: Retifanlimab
Drug: Bevacizumab

Phase 2

The Washington University
The Washington University

Rochester, Minnesota, United States and 3 other locations

This research study is studying several investigational drugs as a possible treatment for Glioblastoma (GBM).The drugs involved in ...

Enrolling
Glioblastoma
Drug: QBS10072S
Drug: Temozolomide

Phase 2

Patrick Wen, MD

Rochester, Minnesota, United States and 11 other locations

This phase II trial tests the safety and side effects of efineptakin alfa and pembrolizumab in treating patients with glioblastoma that has ...

Enrolling
Recurrent Glioblastoma, IDH-Wildtype
Recurrent Gliosarcoma
Biological: Pembrolizumab
Procedure: Biospecimen Collection

Phase 2

Mayo Clinic
Mayo Clinic

Rochester, Minnesota, United States

with progressive or recurrent GBM....

Active, not recruiting
Recurrent GBM
Combination Product: SONALA-001 (ALA) and MR-Guided Focused Ultrasound device (MRgFUS)

Phase 1, Phase 2

SonALASense

Rochester, Minnesota, United States and 5 other locations

This is an open-label, multicenter, randomized, parallel, 2-arm, efficacy and safety study. Patients with GBM after failure of standard firs...

Active, not recruiting
Glioblastoma Multiforme, Adult
Drug: Berubicin
Drug: Lomustine

Phase 2

CNS Pharmaceuticals
CNS Pharmaceuticals

Rochester, Minnesota, United States and 55 other locations

alone versus bevacizumab in patients diagnosed with recurrent glioblastoma (a type of brain cancer, also known as GBM), and to eval...

Active, not recruiting
Recurrent Glioblastoma
Biological: Nivolumab
Biological: Ipilimumab

Phase 3

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Rochester, Minnesota, United States and 112 other locations

To assess:* efficacy of APL-101 as monotherapy for the treatment of NSCLC harboring MET Exon 14 skipping mutations, NSCLC harboring MET amplification...

Enrolling
Glioblastoma Multiforme
Brain Tumor
Drug: APL-101 Oral Capsules

Phase 2

Apollomics

Rochester, Minnesota, United States and 90 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems